Image source: Taxcredits.net via Flickr.
What: After Valeant Pharmaceuticals (NYSE: VRX) reassured investors on Tuesday that it can still deliver on its previously issued full-year financial guidance, shares shot 19.3% higher at 12:30 p.m. EDT.
Image source: Taxcredits.net via Flickr.
What: After Valeant Pharmaceuticals (NYSE: VRX) reassured investors on Tuesday that it can still deliver on its previously issued full-year financial guidance, shares shot 19.3% higher at 12:30 p.m. EDT.